Functional Magnetic Resonance Imaging (fMRI) Imaging Study in Adolescents With Anorexia Nervosa



Status:Completed
Conditions:Psychiatric
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:14 - 18
Updated:4/2/2016
Start Date:June 2009
End Date:January 2011
Contact:Kathryn A Langham, M.D.
Email:kalangham@ucsd.edu
Phone:858-246-0699

Use our guide to learn which trials are right for you!

Neural Dysfunction of Interoception in Adolescents Diagnosed With Anorexia Nervosa

The purpose of this study is to use fMRI imaging technology to examine areas in the brain
related to appetite, reward and cognition in adolescent women with eating disorders as
compared to those who have never had an eating disorder. Better understanding biologic
vulnerabilities in women with anorexia is essential for developing more effective treatment
options.

Individuals with anorexia nervosa (AN) have aberrant feeding behavior, disturbances of
emotionality and impulse control, and have high rates of relapse after weight restoration
(Carter et al., 2004; Halmi et al., 2003). There is no proven treatment that reverses
symptoms. Although imaging studies in individuals recovered from AN (REC AN) suggest that
these symptoms are related to dysfunction of the striatal, insular, and prefrontal areas,
less is known about the biology of these core symptoms in currently ill individuals (ILL
AN). This application will use blood oxygen level-dependent (BOLD) functional magnetic
resonance imaging (fMRI) to examine neural substrates underlying appetitive, reward, and
cognitive dysregulation in ill AN. We will study 22 adolescent women currently ill with AN
and 22 healthy adolescent control women (CW), all of whom are 14 to 18 years old.

The specific aims of the project are:

AIM 1: The anterior insula (AI), orbitofrontal cortex (OFC), and associated regions
integrate sensory/hedonic aspects of taste and interoceptive awareness in the service of
homeostasis. We hypothesize that restricted eating and weight loss occur in AN because a
palatable food elicits little reward.

AIM 2: Little in life is rewarding to individuals with AN aside from weight loss, and they
tend to be overconcerned with future consequences. We predict that ill AN will show an
inability to discriminate positive and negative feedback reflecting aberrant anterior
ventral striatum (AVS) limbic function.

AIM 3: AN tend to be rigid, inflexible and behaviorally inhibited. We will use a stop task
(Band et al., 2003; Logan et al., 1984; Matthews et al., 2005) to characterize the neural
substrates of inhibitory motor control. We hypothesize that ill AN, relative to CW, will
show a demand-specific alteration of a fronto-subthalamic circuit that is necessary for
motor inhibition (Aron et al., 2004).

AIM 4: In an exploratory aim, we propose to examine how clinical, cognitive, and
personality/temperament measures might be correlated to either the BOLD response and/or the
integrity of frontostriatal connectivity as determined using diffusion tensor imaging (DTI).

Taken together, these aims will enable us to better characterize cognitive and limbic
dysfunction in these populations. Understanding biologic vulnerabilities in AN is critical
for developing effective treatment interventions for this often chronic and deadly disorder.
In addition, there is a lack of understanding of appropriate methodologies necessary to
address the unique problems inherent in the study of ill AN. Thus, this project will also
characterize confounding factors, such as brain volume, energy metabolism, development
stages, and gonadal steroids, with the intent that a future project will incorporate the
methodology needed to rigorously investigate this population.

Participants w/ Anorexia Inclusion Criteria

- Female

- Ages 14-18

- Right Handed

- Active AN diagnosis (within last 6 months), excluding amenorrhea criteria

- AN restricting type only

- IBW 70-87% Exclusion Criteria

- Male

- Left Handed

- Does not meet AN criteria within last 6 months

- Alcohol/drug dependence in the 3 months prior to study

- Alcohol/drug use within the 30 days prior to scan. Tox Screen will be administered at
GCRC.

- Use of antipsychotic medication in 3 months prior to study (SSRI OK)

- Current diagnosis of severe major effective d/o or anxiety d/o or other
psychopathology that might interfere with ability to participate e.g requiring
inpatient hospitalization or medication

- Pregnancy or lactation

- Organic brain syndromes, dementia, psychotic disorders or mental retardation

- Neurological or medical disorders such as seizure disorder, renal disease including
pyelonephritis and chronic cystitis, impaired renal function including hyponatremia
(less than 135meq/l), hypokalemia, raised BUN (more than 15mg/dl), diabetes, thyroid
disease (hypo and hyper), EKG indicative of electrolyte imbalance

- Lack of effective birth control during 15 days before the scan. A Urine pregnancy
test will be conducted within 24 hours of the scan

- Insufficient English

Healthy Volunteer Participants Inclusion criteria

- Female

- Ages 14-18

- Right Handed

- IBW between 90% and 120% Exclusion Criteria

- Male

- Left Handed

- Current or past psychiatric (definitive Axis I) disorder

- Alcohol/drug use within the 30 days prior to scan

- Pregnancy or lactation

- Organic brain syndromes, dementia, psychotic disorders or mental retardation

- Neurological or medical illness as indicated by lab tests, medical and psychiatric
histories and physical examination

- Any stigmata suggestive of eating disorder

- Any first degree relatives with an Eating Disorder

- Any first degree relative with a current/past major psychiatric disorder (depression
and alcoholism taken on a case by case basis and measured by severity)

- Insufficient English
We found this trial at
1
site
?
mi
from
La Jolla, CA
Click here to add this to my saved trials